DRUG AFFINITIES FOR THE AGONIST AND ANTAGONIST STATES OF THE OPIOID RECEPTOR

被引：5
作者：
CHENEY, BV
LAHTI, RA
BARSUHN, C
机构：
来源：
EUROPEAN JOURNAL OF PHARMACOLOGY | 1982年 / 77卷 / 04期
关键词：
D O I：
10.1016/0014-2999(82)90127-3
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：259 / 263
页数：5
相关论文
共 50 条
[21]   Abuse Potential and Pharmacodynamic Characteristics of Oral and Intranasal Eluxadoline, a Mixed μ- and κ-Opioid Receptor Agonist and δ-Opioid Receptor Antagonist [J].
Levy-Cooperman, N. ;
McIntyre, G. ;
Bonifacio, L. ;
McDonnell, M. ;
Davenport, J. M. ;
Covington, P. S. ;
Dove, L. S. ;
Sellers, E. M. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2016, 359 (03) :471-481
[22]   Opioid Peptidomimetics: Leads for the Design of Bioavailable Mixed Efficacy μ Opioid Receptor (MOR) Agonist/δ Opioid Receptor (DOR) Antagonist Ligands [J].
Mosberg, Henry I. ;
Yeomans, Larisa ;
Harland, Aubrie A. ;
Bender, Aaron M. ;
Sobczyk-Kojiro, Katarzyna ;
Anand, Jessica P. ;
Clark, Mary J. ;
Jutkiewicz, Emily M. ;
Traynor, John R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (05) :2139-2149
[23]   Longitudinal Measurement of Opioid Receptor Occupancy from Sustained Release Naltrexone: Comparison of Agonist, Partial Agonist and Antagonist Opioid Receptor Radiotracers in Rats [J].
Reed, B. ;
Schoultz, B. ;
Coello, C. ;
Hjornevik, T. ;
Lindblom, I. ;
Henriksen, G. ;
Willoch, F. .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 :S266-S266
[24]   Opioid dipeptide derivatives with a mixed μ agonist δ antagonist, partial μ agonist δ antagonist or μ agonist partial δ agonist profile [J].
Schiller, PW ;
Weltrowska, G ;
Nguyen, TMD ;
Wilkes, BC ;
Lemieux, C ;
Chung, NN .
PEPTIDES FOR THE NEW MILLENNIUM, 2000, :229-230
[25]   Combining an oral opioid-receptor agonist and the antagonist naloxone: A smart drug design that removes some but not all adverse effects of the opioid analgesic [J].
Breivik, Harald ;
Werner, Mads U. .
SCANDINAVIAN JOURNAL OF PAIN, 2014, 5 (02) :72-74
[26]   Opioid Agonist and Antagonist Therapies Prevent Opioid Relapse [J].
Slomski, Anita .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (04) :333-333
[27]   EFFECT OF HOT PLATE TEMPERATURE ON OPIOID AGONIST-ANTAGONIST DRUG ACTIVITY [J].
ZIMET, PO ;
WYNN, PL ;
FORD, R ;
RUDO, FG .
JOURNAL OF DENTAL RESEARCH, 1986, 65 (04) :478-478
[28]   CHANGES IN PITUITARY SECRETION INDUCED BY AN AGONIST-ANTAGONIST OPIOID DRUG, BUPRENORPHINE [J].
ROLANDI, E ;
MARABINI, A ;
FRANCESCHINI, R ;
MESSINA, V ;
BONGERA, P ;
BARRECA, T .
ACTA ENDOCRINOLOGICA, 1983, 104 (03) :257-260
[29]   Preliminary in vitro approach to evaluate the drug-drug interaction potential of EST73502, a dual μ-opioid receptor partial agonist and σ1 receptor antagonist [J].
Ayet, Eva ;
Yeste, Sandra ;
Reinoso, Raquel F. ;
Pretel, Maria Jose ;
Balada, Ariadna ;
Serafini, Maria Teresa .
XENOBIOTICA, 2021, 51 (05) :501-512
[30]   Computational docking and opioidmimetics:: Investigation of δ-opioid agonist and antagonist receptor interactions. [J].
Bryant, S ;
Lazarus, LH ;
Salvadori, S ;
Guerrini, R ;
Balboni, G ;
Jinsmaa, Y .
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 :U461-U461
12345